Key points from article :
Rejuve.Bio uses data from specially bred long-lived fruit flies to develop longevity-enhancing therapies.
They combine fly data with AI and human health data (height, weight, sleep, etc.) to identify new aging targets.
Newer, even longer-lived flies reveal key genes affecting longevity, like those related to metabolism and stress resistance.
Their goal is to collect enough data to offer personalized recommendations for improving individual lifespans.
“We may develop supplements for early intervention and pharmaceutical interventions for age-related disease,” - Kennedy Schaal - Rejuve.Bio's CEO.
The AI platform could be used for various health challenges, not just age-related diseases.
Rejuve.Bio expects their platform to generate promising leads within 6-12 months.
